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Abstract
Introduction: Hemolysis can be induced in sepsis via various mechanisms, its pathophysiological importance has
been demonstrated in experimental sepsis. However, no data on free hemoglobin concentrations in human sepsis
are available. In the present study we measured free hemoglobin in patients with severe sepsis as well as in
postoperative patients using four methods. It was our aim to determine the potential value of free hemoglobin as
a biomarker for diagnosis and outcome of severe sepsis in critical illness.
Methods: Plasma concentration of free hemoglobin was determined in patients with severe sepsis (n = 161) and
postoperative patients (n = 136) on day 1 of diagnosis and surgery. For the measurement of free hemoglobin, an
enzyme linked immunosorbent assay and three spectrophotometric algorithms were used. Moreover, SAPS II- and
SOFA scores as well as procalcitonin concentration and outcome were determined. Kaplan-Meier analysis was
performed and odds ratios were determined after classification of free hemoglobin concentrations in a high and
low concentration group according to the median. For statistical evaluation the Mann-Whitney test and logistic
regression analysis were used.
Results: In non-survivors of severe sepsis, free hemoglobin concentration was twice the concentration compared
to survivors. Thirty-day survival of patients, as evidenced by Kaplan-Meier analysis, was markedly lower in patients
with high free hemoglobin concentration than in patients with low free hemoglobin concentration. Best
discrimination of outcome was achieved with the spectrophotometric method of Harboe (51.3% vs. 86.4% survival,
p < 0.001; odds ratio 6.1). Multivariate analysis including free hemoglobin, age, SAPS II- and SOFA-score and
procalcitonin demonstrated that free hemoglobin, as determined by all 4 methods, was the best and an
independent predictor for death in severe sepsis (p = 0.022 to p < 0.001). Free hemoglobin concentrations were
not significantly different in postoperative and septic patients in three of four assays. Thus, free hemoglobin can
not be used to diagnose severe sepsis in critical illness.
Conclusions: Free hemoglobin is an important new predictor of survival in severe sepsis.
Introduction
Sepsis is the third common cause of death in western
countries, but despite decades of research its prognosis
has not improved markedly [1]. Concerning the pathophy-
siology leading to sepsis, a generalized inappropriate
inflammation has been demonstrated [2]. While localized
inflammation is an effective strategy to defend against
infection, its generalization in sepsis becomes harmful.
Mechanistically, the presence of specific pathogen struc-
tures (so-called pathogen-associated molecular patterns) is
detected by pattern recognition receptors, including Toll-
like receptors, leading to an activation of the immune sys-
tem and coagulation [3]. Similarly, tissue damage, which
can occur during sepsis, leads to the release of endogenous
danger-associated molecular patterns, which promote
inflammation via Toll-like receptors, too [4].
Free hemoglobin has been demonstrated to affect the
inflammatory response in experimental endotoxinemia
and sepsis. In 1961, Davis and Yull postulated, that a
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specific synergism exists between escherichia coli and red
blood cells, the combination of which was lethal on intra-
peritoneal application in animals, whereas neither bac-
teria nor blood alone were lethal [5]. In 1998, Bloom
et al. revealed that free hemoglobin increases the lipopo-
lysaccharide (LPS)-induced release of TNFa in rats [6].
These findings were broadened by Su et al., demonstrat-
ing increased mortality and TNFa levels in LPS-treated
mice after application of hemoglobin [7]. These results
were extended by a recent study demonstrating that low
grade sepsis in mice induced by cecal ligation and punc-
ture leads to the death in animals deficient for heme oxy-
genase 1, while the wild type animals survived [8].
Moreover, the authors demonstrate that the mortality in
mice is associated with higher free hemoglobin concen-
trations, that mortality can be decreased by infusion of
hemopexin to diminish heme levels and that mortality is
increased in patients with low hemopexin concentrations.
Another line of evidence comes from the finding in
patients with severe sepsis, that a heme oxygenase 1 poly-
morphism is associated with outcome [9].
The use of biomarkers for the diagnosis and prognosis
of severe sepsis is important to early identify patients with
the disease, to identify those patients with a bad prognosis
and to guide therapy. The capabilities of the currently
available sepsis markers, the best of which is procalcitonin,
and current clinical and physiological scoring systems, are
far from perfect. It is a main problem of sepsis-marker,
that a differentiation between critical ill patients (for
example, surgical patients) exhibiting limited inflammatory
response from septic patients with generalized inappropri-
ate inflammation is difficult. Therefore, we tested whether
free hemoglobin determined at day 1 can be used as a bio-
marker for the diagnosis and prognosis of severe sepsis in
critical illness. Determination of free hemoglobin has not
been performed in patients with sepsis so far and thus,
eventual measuring errors might occur, as no standard
method has been established in this setting. Therefore, we
determined free hemoglobin with 4 different methods to
increase the validity of our results and to find an appropri-
ate method for the measurement in patients with severe
sepsis.
In the present study, free hemoglobin concentrations
and outcome were determined in patients with severe
sepsis to evaluate whether free hemoglobin can be used
as a biomarker for outcome in severe sepsis. Moreover,
postoperative patients were compared with sepsis
patients to evaluate whether free hemoglobin is able to
diagnose severe sepsis in patients with severe illness.
Materials and methods
Patients
The study was formally and specifically reviewed and
approved by the Ethics Committee of the University
Hospital Essen, the appropriate institutional review
board. Informed written consent was given by probands
and postoperative patients. Informed consent of patients
with sepsis was waived by the ethics committee, but
written informed consent for the use of data was
acquired from the surviving patients after recovery from
the disease. Over a period of two years, 161 patients
admitted to an intensive care unit (ICU) of the Univer-
sity Hospital of Essen were considered eligible for the
study if they fulfilled the criteria for severe sepsis (sepsis
group) [10]. The second cohort comprised patients
admitted to the ICU after surgery, who did not meet the
criteria for sepsis (postoperative group, n = 136). Two
patients in this group died in the postoperative course.
Moreover, free hemoglobin concentration was deter-
mined in 9 healthy probands. A detailed characterization
of patients with sepsis and postoperative controls is
given in Table 1. Plasma obtained from EDTA blood,
drawn for standard laboratory determinations and cen-
trifuged within 2 hours (15 minutes, 2,500 g), was used
for determination of free hemoglobin on day 1 of diag-
nosis and surgery, respectively. Plasma samples were
stored frozen at -70°C. Blood was drawn via an indwel-
ling arterial catheter (postoperative and septic patients)
or via venous puncture (probands). Procalcitonin con-
centration, the simplified acute physiology score II
(SAPS II), and the sequential organ failure assessment
score (SOFA score) were determined on day 1 [11,12].
The amount of packed red blood cell transfusions
within 3 days and 4 weeks before surgery or the diagno-
sis of sepsis, and 30-day survival were also determined.
Determination of free hemoglobin
Plasma hemoglobin concentration was determined using
both ELISA and spectrophotometry. A commercial avail-
able ELISA was performed according to the manu-
facturers’ recommendations (Bethyl Laboratories,
Montgomery, TX, USA). Three spectrophotometric algo-
rithms described in the literature were used to determine
the free hemoglobin concentration from 350 to 750 nm
spectra. The algorithms used were described by Harboe,
Noe, and Fairbanks (the so-called empirical method)
[13-15].
Determination of biomarkers
For the determination of procalcitonin concentration,
the Liaison Brahms PCT assay (Diasorin S.p.A., Sallugia,
Italy) was used.
Statistical analysis
SPSS Version 19 (SPSS Inc., Chicago, Ill, USA) was used
for all statistical procedures. An a priori alpha error
P-value less than 0.05 was considered to indicate statisti-
cal significance.
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Univariate analyses
Free hemoglobin concentrations, as determined by the dif-
ferent methods in patients with and without severe sepsis,
are given as median and quartiles. The Shapiro-Wilkes
test excluded a normal distribution of the free hemoglobin
values obtained with each of the methods used. Therefore,
the Mann-Whitney test was used for statistical evaluation
and nonparametric correlations and significance levels
according to Spearman-Rho were determined to compare
the results of the four assays. The median of the hemoglo-
bin concentration of all patients with sepsis was used for
the definition of the high and low hemoglobin concentra-
tion sub-cohorts. Thereafter, Kaplan-Meier curves were
generated to compare the 30-day survival of septic patients
with high and low hemoglobin concentration; the log rank
test was used for statistical analysis. Odds ratios for death
in severe sepsis in the high and low hemoglobin groups
were calculated, along with the respective 95% confidence
interval (CI) and the significance values using the Chi-
square test. Box plots were generated using SPSS to
demonstrate the median, quartiles, minimum and maxi-
mum values.
Multivariate analyses
For multivariate analysis of possible predictors of 30-day
mortality, logistic regression was used. Age, SAPS II and
SOFA scores, procalcitonin concentration and hemoglobin
concentration were included as continuous variables using
the backward elimination (likelihood ratio) method using
SPSS. Only one of the methods for the determination of
free hemoglobin was included in the analysis to avoid mul-
ticollinearity. Instead, multivariate analysis was repeated
with each of the methods used for the measurement of
free hemoglobin. Analyses were also performed with either
SAPS II or SOFA score, leading to comparable results, and
thus exluding multicollinearity (data not shown).
Results
Free hemoglobin in survivors and non-survivors of sepsis
In the present study 50 out of 161 patients died within
30 days. Comparison of free hemoglobin concentrations
Table 1 Characterization of postoperative patients, survivors and non-survivors of severe sepsis based on 30-day
mortality.
Postoperative patients Survivors of severe sepsis Non-survivors of severe sepsis
Patient characteristics
Patients, n 136 111 50
Age, years 60 (46, 69) 60 (48, 72) 56 (49, 66)
Gender, male/female 68/68 64/47 28/22
Disease severity
SAPS II score 21.5 (16.0, 27.3) 44.0 (31.0, 57.0) 54.0 (40.0, 60.5)
SOFA score 3.0 (1.8, 6.0) 11.0 (8.0, 14.0) 12.0 (10.0, 15.0)
Procalcitonin, ng/ml 1.5 (0.5, 3.7) 3.2 (1.0, 16.0) 3.8 (1.1, 16.7)
Primary diagnosis (n =)
GI disease 20 31 17
GI cancer 40 16 10
Cancer other 22 7 6
Urogenital disease 6 3 2
Urogenital cancer 18 3 2
Cardiovascular 0 24 4
Lung disease 0 19 5
Lung cancer 0 1 2
Other diseases 30 7 2
Infection type (in %)
Gram positive 0 42.9 34.7
Gram negative 0 36.1 32.6
Fungal 0 14.2 18.4
Cultures negative 0 6.8 14.3
Kidney function
Urea, mg/l 140 (100, 203) 410 (230, 540) 490 (300, 745)
Dialysis, % patients 29.4 45.9 80.0
Included are biometric data, primary diagnosis (which was identical to the type of surgery in the postoperative patients), disease severity, and urea obtained
within 24 h of ICU admission. Note, that more than one infection type was determined in several patients. Requirement for dialysis within 30 days is shown.
Values are given as median [quartiles] unless stated otherwise. SAPS II score: simplified acute physiology score II; SOFA score: sequential organ failure assessment
score.
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in survivors and non-survivors using ELISA and spectro-
photometry (three algorithms) demonstrated marked
differences: the median of free hemoglobin concentra-
tion was increased by about 100% in non-survivors, as
evidenced by all four methods used (P = 0.016 to <
0.001, Figure 1). Medians (quartiles) in survivors and
non-survivors obtained with the four methods were as
follows: ELISA 0.034 g/l (0.023, 0.071) vs. 0.054 g/l
(0.024, 0.1389), Harboe 0.057 g/l (0.036, 0.098) vs. 0.147
g/l (0.069, 0.290), Noe 0.068 g/l (0.047, 0.123) vs. 0.185
g/l (0.087, 0.344) and Fairbanks 0.053 g/l (0.030, 0.085)
vs. 0.100 g/l (0.055, 0.208).
In order to generate Kaplan-Meier curves, patients
with severe sepsis were divided in two sub-cohorts
according to the median of the free hemoglobin concen-
trations as determined by the four methods. Higher con-
centrations of free hemoglobin on the first day of
the diagnosis of severe sepsis were associated with sig-
nificantly increased 30-day mortality (Figure 2). Remark-
ably, this association could be demonstrated for each of
the four methods used. Best discrimination between sur-
vivors and non-survivors was obtained using the method
of Harboe (86.4% vs. 51.3% survival, P < 0.001). The
odds ratios for septic patients to die within 30-days,
when free hemoglobin concentration exceeded the med-
ian, were 2.3 (ELISA), 6.1 (Harboe), 5.2 (Noe), and 3.9
(Fairbanks) (Table 2).
Comparison of free hemoglobin concentration, SAPS II
and SOFA score, and procalcitonin concentration as
predictors of survival in sepsis
To compare the importance of free hemoglobin concen-
tration as a predictor of survival in severe sepsis with
other established markers and scores, both univariate
Figure 1 Free hemoglobin concentrations in survivors and non-survivors of severe sepsis as obtained by ELISA and three
spectrophotometric methods. Data are given in boxplots (median, quartile, minimum, maximum). For statistical evaluation the Mann-Whitney
test was used. Spectrophotometric methods were the methods of Harboe [13], Noe [14] and Fairbanks [15].
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analyses and multivariate analyses were performed. Uni-
variate analyses demonstrated that free hemoglobin as
determined with any of the four methods was a good pre-
dictor of death in severe sepsis, while SAPS II score,
SOFA score, and procalcitonin concentration were not
statistically significant in this study (Table 2).
In the multivariate analyses we included age, SAPS II
and SOFA scores, procalcitonin concentration as well as
Figure 2 Kaplan-Meier analyses of 30-day survival of patients with severe sepsis demonstrating the effect of high and low free
hemoglobin concentrations as determined by four methods. Four sets of Kaplan-Meier curves are shown, as analysis was performed with
each of the four methods used for the determination of free hemoglobin. The continuous lines show the survival of patients with free
hemoglobin concentrations lower than the median, and the dotted lines show the survival when free hemoglobin concentration was higher
than the median of all patients with sepsis. Significance levels for the log rank test are given in the figure. Methods used to measure free
hemoglobin were ELISA and the spectrophotometric methods of Harboe [13], Noe [14] and Fairbanks [15].
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free hemoglobin values obtained by one of the methods.
The analysis was repeated for each method of free hemo-
globin determination to avoid multicollinearity. The
results confirm that free hemoglobin concentration, irre-
spective of the method used, is the best and an indepen-
dent predictor of survival in severe sepsis in this study.
Significance levels for the four methods were as follows:
P = 0.022 for ELISA, P < 0.001 for Harboe, P < 0.001 for
Noe, and P < 0.002 for the Fairbanks method. To exclude
collinearity between SAPS II and SOFA scores, analysis
was repeated with either the SAPS II score or the SOFA
score. The results were almost identical and thus exclude
multicollinearity as the reason for the results of the mul-
tivariate analysis (data not shown).
Free hemoglobin in postoperative patients, patients with
severe sepsis and healthy probands
In postoperative patients (n = 136), median free hemo-
globin concentrations, as determined by ELISA and
three different spectrophotometric methods, were in the
range between 0.045 and 0.078 g/l (Figure 3). The med-
ian values for free hemoglobin concentrations in septic
patients (= 161), as determined by these methods, were
in the range between 0.037 and 0.085 g/l. With the
exception of the Fairbanks method, no method showed
significant differences in free hemoglobin concentrations
between postoperative and septic patients (Figure 3).
Thus, free hemoglobin cannot be used to diagnose
severe sepsis in critical illness.
Determination of free hemoglobin in nine healthy pro-
bands did not demonstrate a significant difference com-
pared to postoperative patients and patients with severe
sepsis. Median concentrations (quartiles), as determined
by the methods of Harboe, Noe, and Fairbanks were 0.094
g/l (0.078, 0.143), 0.109 g/l (0.087, 0.153) and 0.063 g/l
(0.023, 0.121), respectively.
Correlation of the four methods used for the
determination of free hemoglobin
To compare the agreement of the four methods used for
determination of free hemoglobin concentration, we
determined the nonparametric correlation coefficient and
significance level according to Spearman-Rho in post-
operative and septic patients. Correlation between the
spectrophotometric methods was best for the methods of
Noe and Harboe with a correlation coefficient > 0.9 in
both postoperative and septic patients. The Spearman-
Rho test demonstrated that correlation between all meth-
ods used for the determination of free hemoglobin was
highly significant (P < 0.001). Data are summarized in
Table 3.
Influence of red blood cell transfusion on free
hemoglobin concentration
Irrespective of the method used to determine free
hemoglobin concentration, there was only one signifi-
cant positive correlation between the free hemoglobin
concentration and the number of packed red blood cell
units transfused within either 3 days or 4 weeks before
surgery or the diagnosis of severe sepsis, respectively.
This significant correlation (between the Noe method
and transfusion within 4 weeks) was not confirmed by
the other methods and thus might best be explained by
the fact that we did not correct for repeat measure-
ments. The details of analysis of free hemoglobin and
transfusions are given in Table 4. Moreover, the number
of packed red blood cell units transfused to patients
before the onset of sepsis was not different in non-survi-
vors of sepsis, with a median (quartiles) of 0.0 (0.0, 0.0)
at 3 days and 0.0 (0.0, 3.0) at 4 weeks, compared to sur-
vivors of sepsis in whom the median (quartiles) was 0.0
(0.0, 0.0) at 3 days and 0.0 (0.0, 4.0) at 4 weeks (P =
0.78 and 0.54, respectively.
Table 2 Univariate analyses demonstrating the association of (A) free hemoglobin concentration and (B) age, SAPS II
score, SOFA score, and procalcitonin with 30-day survival in severe sepsis.
A. Median Odds ratio 95% CI Significance level
ELISA 0.037 g/l 2.33 1.17, 4.65 0.015
Harboe 0.068 g/l 6.06 2.79, 7.80 < 0.001
Noe 0.085 g/l 5.21 2.44, 11.11 < 0.001
Fairbanks 0.059 g/l 3.92 1.90, 8.06 < 0.001
B. Median Odds ratio 95% CI Significance level
Age 57.0 y 1.22 0.63, 2.38 0.560
SAPS II score 47.5 1.92 0.98, 3.79 0.058
SOFA score 11.5 2.07 0.97, 4.43 0.058
Procalcitonin 3.385 ng/ml 1.42 0.68, 2.95 0.351
Patients were grouped according to high and low free hemoglobin determined by the median of the respective value, measured by ELISA, and by the Harboe,
Noe and Fairbanks methods [13-15]. Thereafter, odds ratios for death in severe sepsis were determined. Depicted are the median of the respective value, the
odds ratios, the 95% confidence intervals (95% CI), and the significance levels (Chi square test). SAPS II score: simplified acute physiology score II; SOFA score:
sequential organ failure assessment score.
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Discussion
The present study demonstrates that free hemoglobin
concentrations above the median value, measured in
plasma obtained from patients with severe sepsis on the
first day of the diagnosis, are associated with increased
30-day mortality. Free hemoglobin concentration proved
to be a better marker of outcome than procalcitonin,
SAPS II or SOFA scores.
Measurement of free hemoglobin
Measurement of proteins in plasma samples may be
affected by differences in the composition of proteins,
lipids, and small molecules, which may occur when
comparing samples from postoperative patients and
patients with sepsis. For this reason, we used four meth-
ods for the determination of free hemoglobin, an ELISA,
and spectrophotometry using three algorithms. Of the
three spectrophotometric methods, one algorithm cor-
rects for bilirubin, while the other two methods do not.
Despite these differences in methodology, all spectro-
photometric methods showed a marked, approximately
two-fold increase in free hemoglobin concentration in
non-survivors compared to survivors. Moreover, the
results are confirmed by those obtained from a commer-
cially available hemoglobin ELISA. The results of all
methods are comparable: correlation between the meth-
ods was high, all methods showed an approximately
two-fold increase in free hemoglobin concentration and
Figure 3 Free hemoglobin measured in postoperative patients and patients with severe sepsis using four methods. Free hemoglobin
did not differ in postoperative and septic patients using three of the four methods. Therefore, free hemoglobin cannot serve as a biomarker for
the diagnosis of severe sepsis in critical illness. Data are given in boxplots (median, quartile, minimum, maximum). For statistical evaluation the
Mann-Whitney test was used. Methods used to measure free hemoglobin were ELISA and the spectrophotometric methods of Harboe [13], Noe
[14] and Fairbanks [15].
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mean values in healthy probands, postoperative and sep-
tic patients were similar using the four methods. Thus,
there is ample evidence that the results reflect true
changes in free hemoglobin concentrations.
While there is clear evidence for the detrimental effects
of free hemoglobin in animal models of endotoxinemia
and sepsis (see next paragraph), our study is the first to
report free hemoglobin measurements in humans with
severe sepsis. Interestingly, our results also demonstrate
that the free hemoglobin concentrations show no signifi-
cant differences between healthy probands, postoperative
patients, and patients with severe sepsis (survivors and
non-survivors combined) on the first day of surgery and
diagnosis, respectively. Thus, free hemoglobin cannot
serve as a biomarker for the diagnosis of severe sepsis.
Importantly however, free hemoglobin measured at day 1
was markedly higher in non-survivors of severe sepsis
than in survivors. If the free hemoglobin concentrations
were above the median in patients with severe sepsis, the
prognosis was poor. Odds ratios for death within 30 days
in patients with severe sepsis were between 2.3 and 6.1
depending on the method used for the determination of
free hemoglobin concentration, thus demonstrating a
major effect on mortality. Moreover, both univariate and
multivariate analyses demonstrate that free hemoglobin,
as determined with four different methods is a far better
predictor of death in sepsis than age, SAPS II score,
SOFA score, and procalcitonin concentration. The find-
ing that free hemoglobin concentration as determined in
all patients with severe sepsis, was not significantly ele-
vated in comparison to postoperative patients, can be
explained by our finding that an increase occurred only
in those patients with a poor prognosis. In summary, the
present study demonstrates an important link between
free hemoglobin concentration in plasma and the out-
come of severe sepsis.
Potential mechanisms leading to increased free
hemoglobin in sepsis
In principle, increased free hemoglobin concentrations in
patients with a poor prognosis might be due to an
increased hemolysis and/or a reduced degradation by
endogenous scavenger and detoxification pathways, such
as hemoglobin stabilizing protein, haptoglobin, hemo-
pexin, heme oxygenase-1, and CD 163 [16]. Concerning
potential mechanisms leading to hemolysis in sepsis, var-
ious mechanisms have been proposed. First, some patho-
gens are capable of inducing hemolysis via toxins and it
has been convincingly demonstrated that hemolytic activ-
ity is an important virulence factor [17-19]. Second, fibrin
strands generated by septic disseminated intravascular
coagulation can destroy erythrocytes leading to so called
schistocytes [20,21]. Third, the complement system,
which is activated during sepsis, may impair the viability
of erythrocytes [22]. Fourth, lipopolysaccharides can
affect mechanical membrane properties, thus potentially
promoting cell destruction [23]. Finally, sepsis has been
claimed to induce death of erythrocytes by eryptosis, a
mechanism that shares similarities with apoptosis [24].
Table 3 Nonparametric correlation coefficients between
the free hemoglobin concentrations obtained with four
different methods.
Assay method ELISA Harboe [13] Noe [14] Fairbanks [15]
ELISA 1 0.407 0.412 0.408
1a 0.534a 0.510a 0.484a
1b 0.552b 0.528b 0.512b
Harboe 0.407 1 0.937 0.552
0.534a 1a 0.988a 0.806a
0.552b 1b 0.989b 0.774b
Noe 0.412 0.937 1 0.557
0.510a 0.988a 1a 0.791a
0.528b 0.989b 1b 0.771b
Fairbanks 0.408 0.552 0.557 1
0.484a 0.806a 0.791a 1a
0.512b 0.774b 0.771b 1b
Nonparametric correlation coefficients for postoperative patients are given
without superscript letters; acoefficients for septic patients; bcoefficients
obtained from all patients. Significance levels according to Spearman-Rho
were lower than 0.001 for all correlations.
Table 4 Lack of significant positive correlation between free hemoglobin concentration, as determined with four
methods and packed red blood cell units transfused within 3 days or 4 weeks before surgery, and diagnosis of severe
sepsis, respectively.
ELISA Harboe [13] Noe [14] Fairbanks [15]
3 days/4 weeks 3 days/4 weeks 3 days/4 weeks 3 days/4 weeks
Postoperative patients
Correlation coefficient 0.066/0.076 0.168/0.158 0.169/0.178 0.084/0.094
Significance level 0.455/0.381 0.510/0.066 0.050/0.039 0.331/0.278
Patients with sepsis
Correlation coefficient -0.154/-0.093 -0.204/-0.039 -0.204/-0.041 -0.217/-0.088
Significance level 0.51/0.244 0.01/0.623 0.009/0.604 0.006/0.271
Given are nonparametric correlation coefficients and significance levels according to Spearmen-Rho.
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Further, increased free hemoglobin concentrations
might be due to transfusion of packed red blood cells.
However, in our study no association of free hemoglobin
concentration with transfused red blood cell units was
detectable in either postoperative or septic patients.
Pathophysiological importance of hemolysis
There are different lines of evidence showing a potential
pathophysiological importance of hemolysis. The harmful
effects of blood transfusion, called storage lesions, are
thought to be caused by hemolysis [25]. Infusion of free
hemoglobin to mice treated with LPS increased TNFa con-
centration and mortality, and these effects were blocked by
hemoglobin antibodies [6,26]. Generation of free hemoglo-
bin complexes with LPS result in enhanced biological activ-
ity, and free hemoglobin and heme act synergistically at
various Toll-like receptors [27-29]. Moreover, reduced
heme degradation in heme oxygenase-1-deficient mice
with experimental sepsis is associated with increased mor-
tality in comparison to wild type mice, and increased free
hemoglobin concentrations in mice with high grade cecal
ligature and puncture in comparison to a low grade lesion
has been demonstrated [8]. In line with this finding are the
results of a recent study demonstrating that genotypes of a
heme oxygenase 1 polymorphism affect the outcome of
patients with adult respiratory distress syndrome and that
decreased hemopexin plasma concentrations are indicative
of poor prognosis in sepsis [8,9]. Another aspect of the
pathophysiological importance of free hemoglobin is the
effective nitric oxide scavenging property of the molecule,
causing microvascular perfusion disturbances and an
increase in arterial blood pressure [30].
Further mechanisms, apart from those based on free
hemoglobin, might be involved in the deleterious effects
of hemolysis in sepsis. Ferrous iron has been demon-
strated to catalyze the generation of radicals, which can
modify lipids, proteins and DNA, thus inducing inflam-
mation [31]. Moreover, the finding that the growth of
microbes is critically dependent on iron might serve as a
further explanation for the detrimental effects of hemo-
lysis [32,33]. Hemolysis may also result in the generation
of microparticles, which are able to induce inflammation
and disseminated intravasular coagulation [34].
Is there a causal relationship of free hemoglobin
concentration and outcome in severe sepsis?
While the results of the present study clearly demonstrate a
strong association of free hemoglobin with the outcome of
patients with sepsis, it is not possible in general to prove a
causal relationship in an observation study. As stated
above, however, there is ample evidence for a causal rela-
tionship between free hemoglobin and outcome of sepsis in
animal models: free hemoglobin affects Toll-like receptor
signal transduction, TNFa generation and mortality
[6,29,35]. In addition, the effects of free hemoglobin in
experimental sepsis can be inhibited by hemopexin [8].
Moreover, recent studies demonstrate the mechanisms
leading to the unfavorable effects of free hemoglobin
including oxidation and production of ferryl hemoglobin
and heme generation [36-38]. In humans, the genotypes of
a heme oxygenase-1 polymorphism in adult respiratory dis-
tress syndrome are associated with outcome [9]. Taken
together, these findings suggest an outstanding importance
of hemoglobin and its derivatives. The results of our study
are in accordance to these experimental findings: however,
an association of free hemoglobin with outcome is no proof
for causality. Moreover, it seems necessary to investigate
the eventual contribution of free iron and microparticles to
the deleterious effects of hemolysis in human severe sepsis.
Which method for free hemoglobin measurement might
be best suitable as predictor of death in severe sepsis?
The results demonstrate that all methods used are appro-
priate as predictors of death in severe sepsis. However,
odds ratios were higher with spectrophotometric assays
than with the ELISA. Although we can only speculate on
the reasons for this result, it is advantageous that the best
prediction of death was achieved with the very simple and
inexpensive spectrophotometric method of Harboe. How-
ever, further studies are necessary to determine the best
method for determination of free hemoglobin in severe
sepsis.
Conclusions
The results of the present study reveal that concentra-
tions of free hemoglobin above the median value mea-
sured on the first day of severe sepsis are associated
with increased 30-day mortality. The results suggest that
the experimental findings of detrimental effects of free
hemoglobin in experimental models may be relevant in
patients with severe sepsis.
Key messages
• Free hemoglobin is a better predictor of outcome
than procalcitonin, SAPS II and SOFA scores.
• The increase of free hemoglobin concentration on
day 1 of severe sepsis in patients with a poor prog-
nosis is compatible with the notion from experimen-
tal findings of an involvement of free hemoglobin in
the pathophysiology of severe sepsis.
• The spectrophotometric method of Harboe is a
simple and inexpensive method for the prediction of
outcome in severe sepsis.
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